Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transforming Hypertension Treatment in Nigeria - Aim 3
NCT07589387Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2026
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
Open-label, single-arm trial in diabetes mellitus (DM), sponsored by Washington University School of Medicine. Primary endpoints: Dose of quarterly supportive supervision visits at 36 months and Difference in 6-month rolling average of blood glucose control at 36 months. Started Feb 2026; status: recruiting.
02
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT07589387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07589387.